Clinical Trials Directory

Trials / Completed

CompletedNCT04223323

Effects of Almond Consumption on the Human Gastrointestinal Microbiota and Metabolic Health

SNACKing Study: Effects of Snacking on the Gastrointestinal Microbiota and Metabolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Illinois at Urbana-Champaign · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

The proposed work will investigate the effect of almond consumption as a snack on human gastrointestinal microbiota and on metabolic health.

Detailed description

This study is a randomized, controlled, investigator-blinded, parallel arm design with two treatment conditions. There will be a phone screening, in person pre-intervention testing, a one-week baseline period devoid of all nuts and seeds followed by a 12-week intervention period, and a post-testing appointment. Participants will be randomized to consume almonds or isocaloric snack for 12 weeks. Participants will provide stool samples during baseline testing and during the 12th week of the intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAlmondsParticipants in the intervention group will consume 2oz of almonds daily over the course of 12 weeks.
DIETARY_SUPPLEMENTPretzelsParticipants in the control group will consume an isocaloric amount of pretzels daily over the course of 12 weeks.

Timeline

Start date
2020-02-10
Primary completion
2023-12-20
Completion
2023-12-20
First posted
2020-01-10
Last updated
2024-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04223323. Inclusion in this directory is not an endorsement.